Overview

The largest consensus on the preferability of proton over photon radiation therapy is in paediatric oncology. Counting 70-80% survival rates, finding solutions that positively impact quality of life outcomes has become a growing focal point among paediatric oncologists.

Proton beams’ physical and biological properties support an advantageous quality of dose distribution, resulting in improved therapeutic gains. The clinical interest lies in the comparative impact of proton beam therapy versus alternatives such as photon beam treatment, either as a curative solution or salvage remedy for cancerous and noncancerous conditions and their effect on survival, disease progression, safety, health-related quality of life and other patient outcomes. An increasing emphasis on evidence-based medicine makes it worthwhile to assess the available data that supports proton therapy over other techniques to better guide the physician and patient toward the most appropriate treatment.

This white paper presents clinical outcomes data that proton therapy provides an effective means to achieve this end.

IBA White Paper

*Please refer to the Terms and Conditions of this website when leaving the site and viewing third party content.